Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Belinostat

EU orphan designation number: EU/3/12/1055   
Active ingredient: Belinostat
Indication: Treatment of peripheral T-cell lymphoma (nodal, other extranodal and leukaemic/disseminated)
Sponsor: Onxeo DK, Filial af Onxeo S.A., Frankrig
c/o Symbion, Fruebjergvej 3, 2100 Copenhagen Ø, Danmark

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
12/10/2012 Orphan Designation EMA/OD/103/12 (2012)7232 of 10/10/2012
29/06/2015 Transfer of orphan designation EMA/OD/103/12/T/01 (2015)4501 of 25/06/2015